Home › Neurofibrosarcoma › Illinois
Neurofibrosarcoma clinical trials in Illinois
3 studies for Neurofibrosarcoma are looking for participants at sites in Illinois.
Cities in Illinois
Safety and Tolerability of TNG462 in Patients With MTAP-deleted Solid Tumors
- University Chicago Medicine, Chicago
- Carle Cancer Center, Urbana
- Midwestern Regional Medical Center, City of Hope Chicago, Zion
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Sep 8, 2026 · NCT05732831NRSTS2021, A Risk Adapted Study Evaluating Maintenance Pazopanib, Limited Margin, Dose-Escalated Radiation Therapy and Selinexor in Non-Rhabdomyosarcoma Soft Tissue Sarcoma (NRSTS)
- Lurie Children's Hospital of Chicago, Chicago
RecruitingPhase 1/2
Up to age 30 · All sexes · Updated Aug 3, 2026 · NCT06239272A Study of Selinexor in People With Wilms Tumors and Other Solid Tumors
- Ann & Robert H. Lurie Children'S Hospital of Chicag, Chicago
RecruitingPhase 2
12 Months · All sexes · Updated May 6, 2026 · NCT05985161From ClinicalTrials.gov, data retrieved Sep 30, 2026. Each study sets its own eligibility; the study team decides who can join.